NRG-GI003

Open to Accrual

Return to Protocol Table

A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma

Principal Investigator

Theodore Hong, MD

Status

Open to Accrual

Date Opened To Accrual

June 21 2017

Disease Site

Gastrointestinal [GI]

Liver

Phase

III

Developmental Therapeutics

Primary Objective

To determine if overall survival (OS) is different for hepatocellular carcinoma patients treated with protons compared to photons.

Patient Population

Patients with pathologically (histologically or cytologically) or radiographically proven (based on the American Association for the Study of Liver Diseases criteria) unresectable or locally recurrent hepatocellular cancer

Target Accrual

167

Protocol Documents

Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.

Patient Study Webpage

To learn more about this study, visit the Patient Study Webpage.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.